Where Conventional IBD Therapies Fall Short
Ugo Iroku, MD, MHS
Michael Dolinger, MD, MBA
Defining Success in IBD: Treat-to-Target
Florence Odufalu, MD
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
IBD Care Reimagined: Personalized, Proactive, and Target-Driven Management
David T. Rubin, MD
The Future of Biologic Treatment in IBD: What’s on the Horizon
Gut-Selective Therapy: Understanding Anti-Integrins in IBD
Small Molecules in IBD: JAK Inhibitors and S1P Modulators
Setting the Stage: Why Rethinking IBD Care Matters Now
Translating Advances into Practice: Lessons from Today’s IBD Landscape
IBD in Focus: A Case-Based Approach to Diagnosis and Assessment
Pathophysiology of IBD: The War Within
Targeting Inflammation in IBD: Localized vs Systemic Strategies
Beyond Biology: Environmental and Lifestyle Influences in IBD
Genetic Susceptibility in IBD: From Risk Genes to Clinical Impact
Case Review: Can You Crack This IBD Case?
David Rubin, MD
Kimberly D. Orleck, PA-C
Switching Strategies: Switch or Stay—What’s Your Call?
Brooke Hodnick, PA-C, MPAS
IBD Immunopathogenesis: Do You Know What You're Blocking?
Loading...
We're glad to see you're enjoying Crohn's Colitis Professional… but how about a more personalized experience?
Press cancel to remain on Crohn's Colitis Professional. Press the link below or the continue button to keep going.